These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14618682)

  • 1. Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study.
    Le Masurier M; Houston G; Cowen P; Grasby P; Sharp T; Hume S
    Synapse; 2004 Feb; 51(2):151-7. PubMed ID: 14618682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents.
    Houston GC; Hume SP; Hirani E; Goggi JL; Grasby PM
    Synapse; 2004 Mar; 51(3):206-12. PubMed ID: 14666518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
    Pedersen K; Simonsen M; Østergaard SD; Munk OL; Rosa-Neto P; Olsen AK; Jensen SB; Møller A; Cumming P
    Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
    Leyton M; Dagher A; Boileau I; Casey K; Baker GB; Diksic M; Gunn R; Young SN; Benkelfat C
    Neuropsychopharmacology; 2004 Feb; 29(2):427-32. PubMed ID: 14583741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
    Martinez D; Slifstein M; Broft A; Mawlawi O; Hwang DR; Huang Y; Cooper T; Kegeles L; Zarahn E; Abi-Dargham A; Haber SN; Laruelle M
    J Cereb Blood Flow Metab; 2003 Mar; 23(3):285-300. PubMed ID: 12621304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats.
    McTavish SF; Raumann B; Cowen PJ; Sharp T
    Eur J Pharmacol; 2001 Jul; 424(2):115-9. PubMed ID: 11476757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased binding potential of [(11)C]raclopride during unilateral continuous microinjection of nicotine in rat striatum observed by positron emission tomography.
    Tajima T; Hatano K; Suzuki M; Ogawa M; Sakiyama Y; Kato T; Endo H; Miura H; Matsubara M; Ito K
    Synapse; 2007 Dec; 61(12):943-50. PubMed ID: 17787002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the amphetamine-evoked dopamine release in the brain of the Göttingen minipig.
    Lind NM; Olsen AK; Moustgaard A; Jensen SB; Jakobsen S; Hansen AK; Arnfred SM; Hemmingsen RP; Gjedde A; Cumming P
    Brain Res Bull; 2005 Feb; 65(1):1-9. PubMed ID: 15680539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C
    Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine.
    Schiffer WK; Logan J; Dewey SL
    Neuropsychopharmacology; 2003 Dec; 28(12):2192-8. PubMed ID: 12888780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
    Gallezot JD; Kloczynski T; Weinzimmer D; Labaree D; Zheng MQ; Lim K; Rabiner EA; Ridler K; Pittman B; Huang Y; Carson RE; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2014 Mar; 39(4):866-74. PubMed ID: 24220025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride.
    Barrett SP; Boileau I; Okker J; Pihl RO; Dagher A
    Synapse; 2004 Nov; 54(2):65-71. PubMed ID: 15352131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primate.
    Narendran R; Slifstein M; Hwang DR; Hwang Y; Scher E; Reeder S; Martinez D; Laruelle M
    Synapse; 2007 Feb; 61(2):106-9. PubMed ID: 17117423
    [No Abstract]   [Full Text] [Related]  

  • 20. Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity.
    Alexoff DL; Vaska P; Marsteller D; Gerasimov T; Li J; Logan J; Fowler JS; Taintor NB; Thanos PK; Volkow ND
    J Nucl Med; 2003 May; 44(5):815-22. PubMed ID: 12732684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.